Peter C. Van Bodegom
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
-
- Cancer Genomics and Diagnostics
Papers in
-
- Lung Cancer Treatments and Mutations 3
- Lung Cancer Diagnosis and Treatment 3
- Tracheal and airway disorders 2
- Oncology 4
- Lung Cancer Research Studies 3
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- W. J. Mooi (1 shared paper)Sjoerd Rodenhuis (1 shared paper)Robbert J.C. Slebos (1 shared paper)S S Wagenaar (2 shared papers)Johannes L. Bos (1 shared paper)Siegina G. Evers (1 shared paper)R.G.J.R.A. Vanderschueren (3 shared papers)Sjoerd Sc. Wagenaar (2 shared papers)
- Journals
- Immunology Letters (1 paper)Cancer (1 paper)Lung Cancer (1 paper)Thorax (1 paper)Supportive Care in Cancer (1 paper)
- Partner nations
- NetherlandsGermanyAustria
In The Last Decade
Peter C. Van Bodegom
9 papers receiving 615 citations
Peers
Comparison fields: 5 of 60
- Oncology 274
- Cancer Research 137
- Pulmonary and Respiratory Medicine 285
- Molecular Biology 234
- Neurology 45
Countries citing papers authored by Peter C. Van Bodegom
This map shows the geographic impact of Peter C. Van Bodegom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Van Bodegom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Van Bodegom more than expected).
Fields of papers citing papers by Peter C. Van Bodegom
This network shows the impact of papers produced by Peter C. Van Bodegom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Van Bodegom. The network helps show where Peter C. Van Bodegom may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter C. Van Bodegom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. | 1988 | 402 |
| 2 | 1989 | 84 | |
| 3 | 1991 | 82 | |
| 4 | 1989 | 47 | |
| 5 | 1986 | 26 | |
| 6 | 1993 | 5 | |
| 7 | 1991 | 3 | |
| 8 | [5 cases of reactive arthritis following a Shigella flexneri epidemic in the Netherlands]. | 1985 | 1 |
| 9 | Quantitative pathologic analysis of first and second primary cancers in double tumors of the lung. | 1989 | 1 |
About Peter C. Van Bodegom
Peter C. Van Bodegom is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Surgery and Molecular Biology, having authored 9 papers that have together received 651 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Tracheal and airway disorders (2 papers), Multiple and Secondary Primary Cancers (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Immunotherapy and Immune Responses (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Oncology (274 citations), Cancer Research (137 citations), Pulmonary and Respiratory Medicine (285 citations), Molecular Biology (234 citations) and Neurology (45 citations). Peter C. Van Bodegom has collaborated with scholars based in Netherlands, Germany and Austria. Frequent co-authors include W. J. Mooi, Sjoerd Rodenhuis, Robbert J.C. Slebos, S S Wagenaar, Johannes L. Bos, Siegina G. Evers, R.G.J.R.A. Vanderschueren, Sjoerd Sc. Wagenaar, J. P. A. Baak and B Corrin. Their work appears in journals such as Immunology Letters, Cancer, Lung Cancer, Thorax and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.